Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot Q9Y6D9 (MD1L1_HUMAN)

Last modified November 25, 2008. Version 63. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Mitotic spindle assembly checkpoint protein MAD1
Alternative name(s):
    Mitotic arrest deficient-like protein 1
    MAD1-like 1
    Mitotic checkpoint MAD1 protein-homolog
      Short name=HsMAD1
      Short name=hMAD1
    Tax-binding protein 181
Gene names
Name: MAD1L1
Synonyms: MAD1, TXBP181
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length718 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Component of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate. Has a role in the correct positioning of the septum. Required for anchoring MAD2L1 to the nuclear periphery.

Subunit structure

Homodimer. Heterodimerizes with MAD2L1 in order to form a tetrameric MAD1L1-MAD2L1 core complex. Perturbation of the original MAD1L1-MAD2L1 structure by the spindle checkpoint may decrease MAD2L1 affinity for MAD1L1. CDC20 can compete with MAD1L1 for MAD2L1 binding, until the attachment and/or tension dampen the checkpoint signal, preventing further release of MAD2L1 on to CDC20. Also able to interact with the BUB1/BUB3 complex and the viral Tax protein.

Subcellular location

Nucleus. Note= From the beginning to the end of mitosis, it is seen to move from a diffusely nuclear distribution to the centrosome, to the spindle midzone and finally to the midbody.

Tissue specificity

Expressed weakly at G0/G1 and highly at late S and G2/M phase.

Induction

Increased by TP53.

Post-translational modification

Phosphorylated; by BUB1. Become hyperphosphorylated in late S through M phases or after mitotic spindle damage. Phosphorylated upon DNA damage, probably by ATM or ATR.

Involvement in disease

Defects in MAD1L1 are involved in the development and/or progression of various types of cancer.

Sequence similarities

Belongs to the MAD1 family.

Sequence caution

The sequence AAC52059.1 differs from that shown. Reason: Frameshift at position 663.

Ontologies

Keywords

   Biological processCell cycle
Cell division
Mitosis
   Cellular componentNucleus
   Coding sequence diversityPolymorphism
   DiseaseDisease mutation
   DomainCoiled coil
   PTMPhosphoprotein
   Technical term3D-structure

Gene Ontology (GO)

   Biological processcell division

Inferred from electronic annotation. Source: UniProtKB-KW

mitotic anaphase Ref.1

Non-traceable author statement. Source: UniProtKB

mitotic cell cycle checkpoint Ref.1

Non-traceable author statement. Source: UniProtKB

mitotic metaphase Ref.1

Non-traceable author statement. Source: UniProtKB

mitotic telophase Ref.1

Non-traceable author statement. Source: UniProtKB

   Cellular componentcentrosome Ref.1

Non-traceable author statement. Source: UniProtKB

cytosol Ref.13

Inferred from Experiment. Source: Reactome

nucleus

Inferred from electronic annotation. Source: UniProtKB-KW

spindle Ref.1

Non-traceable author statement. Source: UniProtKB

   Molecular functionprotein binding

Inferred from physical interaction. Source: IntAct

Complete GO annotation...

Binary interactions

With

Entry

#Exp.

IntAct

Notes

MAD2L1Q132572EBI-742610,EBI-78203
MAXP612442EBI-742610,EBI-878388

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 718718Mitotic spindle assembly checkpoint protein MAD1
PRO_0000213800

Regions

Coiled coil46 – 632587 Potential

Amino acid modifications

Modified residue161Phosphoserine
Modified residue2141Phosphoserine
Modified residue4281Phosphoserine

Natural variations

Natural variant291S → L in a lymphoid cancer cell line; somatic mutation.
VAR_019707
Natural variant591R → C in a prostate cancer cell line; somatic mutation.
VAR_019708
Natural variant1601N → S
VAR_019709
Natural variant2991T → A in lung cancer cell line; somatic mutation.
VAR_019710
Natural variant3601R → Q in a prostate cancer cell line; somatic mutation.
VAR_019711
Natural variant5001T → M
VAR_019712
Natural variant5111E → K
VAR_019713
Natural variant5161E → K in a breast cancer cell line; somatic mutation.
VAR_019714
Natural variant5561R → C in a prostate cancer cell line; somatic mutation.
VAR_019715
Natural variant5561R → H in one individual with lung cancer.
VAR_019716
Natural variant5581R → H in a cancer cell line.
VAR_019717
Natural variant5691E → K in a breast cancer cell line; somatic mutation.
VAR_019718
Natural variant5721R → H in a cancer cell line.
VAR_019719

Experimental info

Sequence conflict189 – 1902EL → DV in AAC52059. Ref.1
Sequence conflict189 – 1902EL → DV in AAD24498. Ref.2
Sequence conflict2601K → E in AAC52059. Ref.1
Sequence conflict2601K → E in AAD24498. Ref.2
Sequence conflict2681Missing in AAC52059. Ref.1

Secondary structure

............ 718
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Q9Y6D9-1 [UniParc].

Last modified September 27, 2004. Version 2.
Checksum: DA65529856A37EE3

FASTA71883,067
        10         20         30         40         50         60 
MEDLGENTMV LSTLRSLNNF ISQRVEGGSG LDISTSAPGS LQMQYQQSMQ LEERAEQIRS 

        70         80         90        100        110        120 
KSHLIQVERE KMQMELSHKR ARVELERAAS TSARNYEREV DRNQELLTRI RQLQEREAGA 

       130        140        150        160        170        180 
EEKMQEQLER NRQCQQNLDA ASKRLREKED SLAQAGETIN ALKGRISELQ WSVMDQEMRV 

       190        200        210        220        230        240 
KRLESEKQEL QEQLDLQHKK CQEANQKIQE LQASQEARAD HEQQIKDLEQ KLSLQEQDAA 

       250        260        270        280        290        300 
IVKNMKSELV RLPRLERELK QLREESAHLR EMRETNGLLQ EELEGLQRKL GRQEKMQETL 

       310        320        330        340        350        360 
VGLELENERL LAKLQSWERL DQTMGLSIRT PEDLSRFVVE LQQRELALKD KNSAVTSSAR 

       370        380        390        400        410        420 
GLEKARQQLQ EELRQVSGQL LEERKKRETH EALARRLQKR VLLLTKERDG MRAILGSYDS 

       430        440        450        460        470        480 
ELTPAEYSPQ LTRRMREAED MVQKVHSHSA EMEAQLSQAL EELGGQKQRA DMLEMELKML 

       490        500        510        520        530        540 
KSQSSSAEQS FLFSREEADT LRLKVEELEG ERSRLEEEKR MLEAQLERRA LQGDYDQSRT 

       550        560        570        580        590        600 
KVLHMSLNPT SVARQRLRED HSQLQAECER LRGLLRAMER GGTVPADLEA AAASLPSSKE 

       610        620        630        640        650        660 
VAELKKQVES AELKNQRLKE VFQTKIQEFR KACYTLTGYQ IDITTENQYR LTSLYAEHPG 

       670        680        690        700        710 
DCLIFKATSP SGSKMQLLET EFSHTVGELI EVHLRRQDSI PAFLSSLTLE LFSRQTVA 

« Hide

References

« Hide 'large scale' references
[1]"Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1."
Jin D.-Y., Spencer F., Jeang K.-T.
Cell 93:81-91(1998) [PubMed: 9546394] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], HOMODIMERIZATION, HETEROTETRAMER, SUBCELLULAR LOCATION, PHOSPHORYLATION, INTERACTION WITH MAD2L1 AND VIRAL TAX.
[2]"Mitotic checkpoint locus MAD1L1 maps to human chromosome 7p22 and mouse chromosome 5."
Jin D.-Y., Kozak C.A., Pangilinan F., Spencer F., Green E.D., Jeang K.-T.
Genomics 55:363-364(1999) [PubMed: 10049595] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], INDUCTION, FUNCTION.
[3]Seeley T.W.
Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE.
Tissue: Testis.
[4]"The DNA sequence of human chromosome 7."
Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. expand/collapse author list , Nash W.E., Cordes M., Du H., Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C., Latreille P., Miller N., Johnson D., Murray J., Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E., Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H., Wilson R.K.
Nature 424:157-164(2003) [PubMed: 12853948] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[5]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Pancreas.
[6]"Phosphorylation of human MAD1 by the BUB1 kinase in vitro."
Seeley T.W., Wang L., Zhen J.Y.
Biochem. Biophys. Res. Commun. 257:589-595(1999) [PubMed: 10198256] [Abstract]
Cited for: PHOSPHORYLATION BY BUB1, INTERACTION WITH BUB1/BUB3 COMPLEX.
[7]"Large-scale characterization of HeLa cell nuclear phosphoproteins."
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, MASS SPECTROMETRY.
Tissue: Epithelium.
[8]"A probability-based approach for high-throughput protein phosphorylation analysis and site localization."
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.
Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, MASS SPECTROMETRY.
Tissue: Epithelium.
[9]"Phosphoproteome analysis of the human mitotic spindle."
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006) [PubMed: 16565220] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, MASS SPECTROMETRY.
Tissue: Epithelium.
[10]"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage."
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.
Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214, MASS SPECTROMETRY.
[11]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, MASS SPECTROMETRY.
[12]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-428, MASS SPECTROMETRY.
[13]"Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint."
Sironi L., Mapelli M., Knapp S., De Antoni A., Jeang K.-T., Musacchio A.
EMBO J. 21:2496-2506(2002) [PubMed: 12006501] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 493-579 IN COMPLEX WITH MAD2L1, COMPETITIVE INHIBITOR OF MAD2L1-CDC20 INTERACTION.
[14]"Characterization of MAD2B and other mitotic spindle checkpoint genes."
Cahill D.P., da Costa L.T., Carson-Walter E.B., Kinzler K.W., Vogelstein B., Lengauer C.
Genomics 58:181-187(1999) [PubMed: 10366450] [Abstract]
Cited for: VARIANTS HIS-558 AND HIS-572.
[15]"Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers."
Nomoto S., Haruki N., Takahashi T., Masuda A., Koshikawa T., Takahashi T., Fujii Y., Osada H., Takahashi T.
Oncogene 18:7180-7183(1999) [PubMed: 10597320] [Abstract]
Cited for: VARIANT LUNG CANCER ALA-299, VARIANTS SER-160; MET-500; LYS-511; HIS-556 AND HIS-558.
[16]"Mutations in the mitotic check point gene, MAD1L1, in human cancers."
Tsukasaki K., Miller C.W., Greenspun E., Eshaghian S., Kawabata H., Fujimoto T., Tomonaga M., Sawyers C., Said J.W., Koeffler H.P.
Oncogene 20:3301-3305(2001) [PubMed: 11423979] [Abstract]
Cited for: VARIANTS CANCER LEU-29; CYS-59; GLN-360; LYS-516; CYS-556 AND LYS-569, VARIANTS MET-500 AND HIS-558.
+Additional computationally mapped references.

Cross-references

Sequence databases

U33822 mRNA. Translation: AAC52059.1. Frameshift.
AF083811 mRNA. Translation: AAD24498.1.
AF123318 mRNA. Translation: AAD20359.1.
AC005282 Genomic DNA. No translation available.
AC006433 Genomic DNA. No translation available.
AC069288 Genomic DNA. Translation: AAS07503.1.
AC104129 Genomic DNA. Translation: AAP21876.1.
AC110781 Genomic DNA. No translation available.
BC009964 mRNA. Translation: AAH09964.1.
RefSeqNP_001013858.1.
NP_001013859.1.
NP_003541.2.
UniGeneHs.654838

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
1GO4X-ray2.05E/F/G/H485-584[»]
ModBaseSearch...

Protein-protein interaction databases

IntActQ9Y6D9.

PTM databases

PhosphoSiteQ9Y6D9.

Proteomic databases

PeptideAtlasQ9Y6D9.

Genome annotation databases

EnsemblENSG00000002822. Homo sapiens. [Contig view]
GeneID8379.
KEGGhsa:8379.

Organism-specific databases

H-InvDBHIX0006424.
HGNCHGNC:6762. MAD1L1.
HPACAB015338.
HPA003635.
MIM602686. gene.
PharmGKBPA372.
GenAtlasSearch...
GeneCardsSearch...

Phylogenomic databases

HOGENOMQ9Y6D9.
HOVERGENQ9Y6D9.

Enzyme and pathway databases

ReactomeREACT_1538. Cell Cycle Checkpoints.

Gene expression databases

ArrayExpressQ9Y6D9.
CleanExHS_MAD1L1.
GermOnlineENSG00000002822. Homo sapiens.

Family and domain databases

InterProIPR008672. MAD.
[Graphical view]
PfamPF05557. MAD. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

LinkHubQ9Y6D9.
NextBio31368.
SOURCESearch...

Entry information

Entry nameMD1L1_HUMAN
AccessionPrimary (citable) accession number: Q9Y6D9
Secondary accession number(s): Q13312 expand/collapse secondary AC list , Q75MI0, Q86UM4, Q9UNH0
Entry history
Integrated into UniProtKB/Swiss-Prot: September 27, 2004
Last sequence update: September 27, 2004
Last modified: November 25, 2008
This is version 63 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 7

Human chromosome 7: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents